Delivery Order SPE2DX22D0020-SPE2D826F12HS
- Not listed
- This delivery order, awarded on January 6, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain, carries a ceiling value of $3,896.70 and is scheduled for ultimate completion by January 7, 2026. The award is a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. The contractor is based in Conshohocken, Pennsylvania, where AmerSourceBergen maintains its corporate office and...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,189.08 to AmerSourceBergen Drug Corp on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order is a child contract executed under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The award was made without a set-aside...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- This delivery order, awarded on December 8, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999.999 billion through December 2026. The delivery order itself carries a ceiling value of $24,902.97 under firm fixed pricing with an ultimate completion date of December 9, 2025. The contract was competitively awarded with no set-aside designation to...
- This delivery order, awarded January 6, 2026, provides $10,009.14 in firm fixed-price pharmaceutical supplies to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., through the Defense Logistics Agency's Medical Supply Chain. The award represents a single delivery order with an ultimate completion date of January 7, 2026, and carries no set-aside designation, indicating it was competitively awarded. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This delivery order, valued at $1,069.20, was awarded to AmerisourceBergen Drug Corp on October 4, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of October 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract vehicle, this delivery order represents one of numerous...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,109.36 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- This delivery order, awarded on October 5, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order has a ceiling value of $1,036.80 and is structured as a firm fixed price contract with no set-aside designation, indicating competitive award authority. The contract is funded through the Medical Supply Chain, a...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F12HSDelivery Order
This delivery order, awarded January 6, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency Medical Supply Chain, carries a ceiling value of $1,127.28 with a firm fixed price structure. The contract is not set aside and represents a child order under a larger indefinite delivery contract vehicle. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor supplying a comprehensive range of medical products to federal agencies, with particular focus on military and veteran healthcare systems. This delivery order is issued under AmerSourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., also maintains a larger $999,999,999.00 IDC with DLA Troop Support Medical extending through December 31, 2031. These contract vehicles serve as comprehensive global pharmaceutical support mechanisms, enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/5/26 |